Role of Astrocytes in Brain Function and Disease

Toxicologic Pathology

Volumn 39, Issue 1, 2011, Pages 115-123

  Sidoryk Wegrzynowicz, Marta ^a   Wegrzynowicz, Michal ^a   Lee, Eunsook ^b   Bowman, Aaron B ^a   Aschner, Michael ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

astrocyte; nervous system; neurodegenerative diseases

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ALZHEIMER DISEASE; ANIMAL; ASTROCYTE; BRAIN; HEPATIC ENCEPHALOPATHY; HUMAN; METABOLISM; NERVE CELL; NERVOUS SYSTEM FUNCTION; PARKINSON DISEASE; PATHOLOGY; REVIEW; SECRETION;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BRAIN; HEPATIC ENCEPHALOPATHY; HUMANS; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NEURONS; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE;

EID: 79959492122     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310385254     Document Type: Article

References (154)

1. Abramov A. Y. Canevari L. Duchen M. R. (2004). Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742, 81–87.
2. Albrecht J. (2005). Astrocytes in ammonia neurotoxicity: A target, a mediator and a shield. In The Role of Glia in Neurotoxicity (Aschner M. Costa L. G. eds.), pp. 329–42. CRC Press, Boca Raton, FL.
3. Albrecht J. Norenberg M. D. (2006). Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 44, 788–94.
4. Allaman I. Gavillet M. Belanger M. Laroche T. Viertl D. Lashuel H. A. Magistretti P. J. (2010). Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: Impact on neuronal viability. J Neurosci 30, 3326–38.
5. Anderson M. F. Blomstrand F. Blomstrand C. Eriksson P. S. Nilsson M. (2003). Astrocytes and stroke: Networking for survival? Neurochem Res 28, 293–305.
6. Aschner M. LoPachin R. M. (2001). Neurotoxic injury and astrocytes. In Neuroglia in the Aging Brain (de Vellis J. Ed.), pp. 259–74. Totowa, NJ: Humana.
7. Ayata C. Ropper A. H. (2002). Ischaemic brain oedema. J Clin Neurosci 9, 113–24.
8. Bai G. Rama Rao K. V. Murthy C. R. Panickar K. S. Jayakumar A. R. Norenberg M. D. (2001). Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 66, 981–91.
9. Bak L. K. Zieminska E. Waagepetersen H. S. Schousboe A. Albrecht J. (2008). Metabolism of [U-13C]glutamine and [U-13C]glutamate in isolated rat brain mitochondria suggests functional phosphate-activated glutaminase activity in matrix. Neurochem Res 33, 273–78.
10. Baraldi M. Pinelli G. Ricci P. Zeneroli M. L. (1984). Toxins in hepatic encephalopathy: The role of the synergistic effect of ammonia, mercaptans and short chain fatty acids. Arch Toxicol Suppl 7, 103–5.
11. Berl S. Lajtha A. Waelsch H. (1961). Amino acid and protein metabolism of the brain—VI. Cerebral compartments of glutamic acid metabolism. J Neurochem 7, 322–32.
12. Blei A. T. Olafsson S. Therrien G. Butterworth R. F. (1994). Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 19, 1437–44.
13. Blom H. J. Ferenci P. Grimm G. Yap S. H. Tangerman A. (1991). The role of methanethiol in the pathogenesis of hepatic encephalopathy. Hepatology 13, 445–54.
14. Budd S. L. Lipton S. A. (1998). Calcium tsunamis: Do astrocytes transmit cell death messages via gap junctions during ischemia? Nat Neurosci 1, 431–32.
15. Butterworth R. F. (2002). Pathophysiology of hepatic encephalopathy: A new look at ammonia. Metab Brain Dis 17, 221–27.
16. Butterworth R. F. (2007). Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 22, 309–20.
17. Canevari L. Abramov A. Y. Duchen M. R. (2004). Toxicity of amyloid beta peptide: Tales of calcium, mitochondria, and oxidative stress. Neurochem Res 29, 637–50.
18. Cataldo A. M. Broadwell R. D. (1986). Cytochemical identification of cerebral glycogen and glucose-6-phosphatase activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia and pericytes. J Neurocytol 15, 511–24.
19. Cesar M. Hamprecht B. (1995). Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 64, 2312–18.
20. Chen P. C. Vargas M. R. Pani A. K. Smeyne R. J. Johnson D. A. Kan Y. W. Johnson J. A. (2009). Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson’s disease: Critical role for the astrocyte. Proc Natl Acad Sci U S A 106, 2933–38.
21. Chen P. S. Peng G. S. Li G. Yang S. Wu X. Wang C. C. Wilson B. Lu R. B. Gean P. W. Chuang D. M. Hong J. S. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11, 1116–25.
22. Chen Y. Swanson R. A. (2003). Astrocytes and brain injury. J Cereb Blood Flow Metab 23, 137–49.
23. Conn H. O. (1994). The hepatic encephalopathies. In Hepatic Encephalopathy: Syndromes and Therapies (Conn H. O. Bircher J. eds.), pp. 1–12. Medi-Ed Press, Bloomington, IN.
24. Cooper A. J. McDonald J. M. Gelbard A. S. Gledhill R. F. Duffy T. E. (1979). The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254, 4982–92.
25. Copin J. C. Ledig M. Tholey G. (1992). Free radical scavenging systems of rat astroglial cells in primary culture: Effects of anoxia and drug treatment. Neurochem Res 17, 677–82.
26. Cordoba J. Crespin J. Gottstein J. Blei A. T. (1999). Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis. Gastroenterology 116, 686–93.
27. Cordoba J. Gottstein J. Blei A. T. (1996). Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia-induced brain edema. Hepatology 24, 919–23.
28. Dejong C. H. van de Poll M. C. Soeters P. B. Jalan R. Olde Damink S. W. (2007). Aromatic amino acid metabolism during liver failure. J Nutr 137, 1579S–85S; discussion 1597S–98S.
29. Dervan A. G. Meshul C. K. Beales M. McBean G. J. Moore C. Totterdell S. Snyder A. K. Meredith G. E. (2004). Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson’s disease. Exp Neurol 190, 145–56.
30. DeWitt D. A. Perry G. Cohen M. Doller C. Silver J. (1998). Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer’s disease. Exp Neurol 149, 329–40.
31. Diaz-Munoz M. Tapia R. (1989). Functional changes of brain mitochondria during experimental hepatic encephalopathy. Biochem Pharmacol 38, 3835–41.
32. Dolinska M. Hilgier W. Albrecht J. (1996). Ammonia stimulates glutamine uptake to the cerebral non-synaptic mitochondria of the rat. Neurosci Lett 213, 45–48.
33. Dringen R. (2000). Metabolism and functions of glutathione in brain. Prog Neurobiol 62, 649–71.
34. Dringen R. Hirrlinger J. (2003). Glutathione pathways in the brain. Biol Chem 384, 505–16.
35. Dringen R. Pfeiffer B. Hamprecht B. (1999). Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19, 562–69.
36. Faff-Michalak L. Albrecht J. (1991). Aspartate aminotransferase, malate dehydrogenase, and pyruvate carboxylase activities in rat cerebral synaptic and nonsynaptic mitochondria: Effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy. Metab Brain Dis 6, 187–97.
37. Faff-Michalak L. Albrecht J. (1993). The two catalytic components of the 2-oxoglutarate dehydrogenase complex in rat cerebral synaptic and nonsynaptic mitochondria: Comparison of the response to in vitro treatment with ammonia, hyperammonemia, and hepatic encephalopathy. Neurochem Res 18, 119–23.
38. Fawcett J. W. Asher R. A. (1999). The glial scar and central nervous system repair. Brain Res Bull 49, 377–91.
39. Ferenci P. Lockwood A. Mullen K. Tarter R. Weissenborn K. Blei A. T. (2002). Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35, 716–21.
40. Gegelashvili G. Schousboe A. (1997). High affinity glutamate transporters: Regulation of expression and activity. Mol Pharmacol 52, 6–15.
41. Gegelashvili G. Schousboe A. (1998). Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 45, 233–38.
42. Gu X. L. Long C. X. Sun L. Xie C. Lin X. Cai H. (2010). Astrocytic expression of Parkinson’s disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 21, 3–12.
43. Haass C. Selkoe D. J. (1993). Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75, 1039–42.
44. Haberg A. Qu H. Saether O. Unsgard G. Haraldseth O. Sonnewald U. (2001). Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: The role of astrocytes in neuronal survival. J Cereb Blood Flow Metab 21, 1451–63.
45. Harrison P. M. Wendon J. A. Gimson A. E. Alexander G. J. Williams R. (1991). Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324, 1852–57.
46. Hawkins R. A. Jessy J. Mans A. M. De Joseph M. R. (1993). Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 60, 1000–1006.
47. Heikkila R. E. Sieber B. A. Manzino L. Sonsalla P. K. (1989). Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol Chem Neuropathol 10, 171–83.
48. Hertz L. Peng L. Westergaard N. Yudkoff M. Schousboe A. (1992). Neuronal–astrocytic interactions in metabolism of transmitter amino acids of the glutamate family. In Alfred Benzon Symposium 32, Drug Research Related to Neuroactive Amino Acids (Schousboe A. Diemer N. H. Kofod H. eds.), pp. 30–48. Copenhagen, Denmark: Munksgaard.
49. Hilgier W. Anderzhanova E. Oja S. S. Saransaari P. Albrecht J. (2003). Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur J Pharmacol 468, 21–25.
50. Hilgier W. Wegrzynowicz M. Maczewski M. Beresewicz A. Oja S. S. Saransaari P. Albrecht J. (2008). Effect of glutamine synthesis inhibition with methionine sulfoximine on the nitric oxide-cyclic GMP pathway in the rat striatum treated acutely with ammonia: A microdialysis study. Neurochem Res 33, 267–72.
51. Hindfelt B. Plum F. Duffy T. E. (1977). Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 59, 386–96.
52. Hirsch E. C. Hunot S. Damier P. Brugg B. Faucheux B. A. Michel P. P. Ruberg M. Muriel M. P. Mouatt-Prigent A. Agid Y. (1999). Glial cell participation in the degeneration of dopaminergic neurons in Parkinson’s disease. Adv Neurol 80, 9–18.
53. Hornykiewicz O. Kish S. J. (1987). Biochemical pathophysiology of Parkinson’s disease. Adv Neurol 45, 19–34.
54. Ishida Y. Nagai A. Kobayashi S. Kim S. U. (2006). Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: Astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol 65, 66–77.
55. Iwata-Ichikawa E. Kondo Y. Miyazaki I. Asanuma M. Ogawa N. (1999). Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 72, 2334–44.
56. Jayakumar A. R. Rama Rao K. V. Schousboe A. Norenberg M. D. (2004). Glutamine-induced free radical production in cultured astrocytes. Glia 46, 296–301.
57. Jayakumar A. R. Rao K. V. Murthy Ch R. Norenberg M. D. (2006). Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 48, 623–28.
58. Jiang W. Desjardins P. Butterworth R. F. (2009). Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats. Neurochem Int 55, 601–5.
59. Johnstone M. Gearing A. J. Miller K. M. (1999). A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93, 182–93.
60. Jones A. L. (1998). Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: A critical review. J Toxicol Clin Toxicol 36, 277–85.
61. Kaur P. Aschner M. Syversen T. (2007). Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology 230, 164–77.
62. Kimelberg H. K. (2010). Functions of mature mammalian astrocytes: A current view. Neuroscientist 16, 79–106.
63. Knott C. Stern G. Kingsbury A. Welcher A. A. Wilkin G. P. (2002). Elevated glial brain-derived neurotrophic factor in Parkinson’s diseased nigra. Parkinsonism Relat Disord 8, 329–41.
64. Koistinaho M. Lin S. Wu X. Esterman M. Koger D. Hanson J. Higgs R. Liu F. Malkani S. Bales K. R. Paul S. M. (2004). Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10, 719–26.
65. Kosenko E. Felipo V. Montoliu C. Grisolía S. Kaminsky Y. (1996). Effects of acute hyperammonemia in vivo on oxidative metabolism in nonsynaptic rat brain mitochondria. Metab Brain Dis 12, 69–82.
66. Kosenko E. Kaminsky Y. Grau E. Minana M. D. Marcaida G. Grisolia S. Felipo V. (1994). Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+,K(+)-ATPase. J Neurochem 63, 2172–78.
67. Kosenko E. Kaminsky Y. Kaminsky A. Valencia M. Lee L. Hermenegildo C. Felipo V. (1997). Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 27, 637–44.
68. Kurt M. A. Davies D. C. Kidd M. (1999). beta-Amyloid immunoreactivity in astrocytes in Alzheimer’s disease brain biopsies: An electron microscope study. Exp Neurol 158, 221–28.
69. Lajtha A. Berl S. Waelsch H. (1959). Amino acid and protein metabolism of the brain. IV. The metabolism of glutamic acid. J Neurochem 3, 322–32.
70. Lang A. E. Lozano A. M. (1998). Parkinson’s disease. First of two parts. N Engl J Med 339, 1044–53.
71. Largo C. Cuevas P. Herreras O. (1996). Is glia disfunction the initial cause of neuronal death in ischemic penumbra? Neurol Res 18, 445–48.
72. Laubenberger J. Haussinger D. Bayer S. Gufler H. Hennig J. Langer M. (1997). Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 112, 1610–16.
73. Lavoie J. Giguere J. F. Layrargues G. P. Butterworth R. F. (1987). Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 49, 692–97.
74. Lee J. M. Li J. Johnson D. A. Stein T. D. Kraft A. D. Calkins M. J. Jakel R. J. Johnson J. A. (2005). Nrf2, a multi-organ protector? FASEB J 19, 1061–66.
75. Lehre K. P. Levy L. M. Ottersen O. P. Storm-Mathisen J. Danbolt N. C. (1995). Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations. J Neurosci 15, 1835–53.
76. Lin J. H. Weigel H. Cotrina M. L. Liu S. Bueno E. Hansen A. J. Hansen T. W. Goldman S. Nedergaard M. (1998). Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1, 494–500.
77. Lin L. F. Doherty D. H. Lile J. D. Bektesh S. Collins F. (1993). GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–32.
78. Magistretti P. J. Sorg O. Naichen Y. Pellerin L. de Rham S. Martin J. L. (1994). Regulation of astrocyte energy metabolism by neurotransmitters. Ren Physiol Biochem 17, 168–71.
79. Makar T. K. Nedergaard M. Preuss A. Gelbard A. S. Perumal A. S. Cooper A. J. (1994). Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: Evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62, 45–53.
80. Martin D. L. (1992). Synthesis and release of neuroactive substances by glial cells. Glia 5, 81–94.
81. Martinez-Hernandez A. Bell K. P. Norenberg M. D. (1977). Glutamine synthetase: Glial localization in brain. Science 195, 1356–58.
82. Matos M. Augusto E. Oliveira C. R. Agostinho P. (2008). Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 156, 898–910.
83. McConnell J. R. Antonson D. L. Ong C. S. Chu W. K. Fox I. J. Heffron T. G. Langnas A. N. Shaw B. W. Jr. (1995). Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 22, 69–74.
84. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34, 939–44.
85. Mirza B. Hadberg H. Thomsen P. Moos T. (2000). The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95, 425–32.
86. Mizoguchi N. Nishimura Y. Ono H. Sakura N. (2001). Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr 160, 247–50.
87. Mizui T. Kinouchi H. Chan P. H. (1992). Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol 262, H313–17.
88. Montes S. Alcaraz-Zubeldia M. Muriel P. Rios C. (2001). Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res 891, 123–29.
89. Montoliu C. Piedrafita B. Serra M. A. del Olmo J. A. Urios A. Rodrigo J. M. Felipo V. (2009). IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43, 272–79.
90. Mullen K. D. (2007). Review of the final report of the 1998 Working Party on Definition, Nomenclature and Diagnosis of Hepatic Encephalopathy. Aliment Pharmacol Ther 25 (Suppl. 1), 11–16.
91. Murthy C. R. Rama Rao K. V. Bai G. Norenberg M. D. (2001). Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 66, 282–88.
92. Nagele R. G. D’Andrea M. R. Lee H. Venkataraman V. Wang H. Y. (2003). Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 971, 197–209.
93. Nakase T. Sohl G. Theis M. Willecke K. Naus C. C. G. (2004). Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. American J Pathol 164, 2067–75
94. Navarro A. Boveris A. (2009). Brain mitochondrial dysfunction and oxidative damage in Parkinson’s disease. J Bioenerg Biomembr 41, 517–21.
95. Norenberg M. D. (1977). A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Lab Invest 36, 618–27.
96. Norenberg M. D. (1981). The astrocyte in liver disease. In Advances in Cellular Neurobiology 2 (Fedoroff S. Hertz L. eds.), pp. 303–52. San Diego, CA: Academic Press.
97. Norenberg M. D. (1987). The role of astrocytes in hepatic encephalopathy. Neurochem Pathol 6, 13–33.
98. Norenberg M. D. Bender A. S. (1994). Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines. Acta Neurochir Suppl (Wien) 60, 24–27.
99. Olabarria M. Noristani H. N. Verkhratsky A. Rodríguez J. J. (2010). Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease. Glia 58, 831–38.
100. Olafsson S. Gottstein J. Blei A. T. (1995). Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology 108, 1097–1103.
101. Pares A. Deulofeu R. Cisneros L. Escorsell A. Salmeron J. M. Caballeria J. Mas A. (2009). Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 13, R8.
102. Pellerin L. Bouzier-Sore A. K. Aubert A. Serres S. Merle M. Costalat R. Magistretti P. J. (2007). Activity-dependent regulation of energy metabolism by astrocytes: An update. Glia 55, 1251–62.
103. Pellerin L. Magistretti P. J. (2004). Neuroenergetics: Calling upon astrocytes to satisfy hungry neurons. Neuroscientist 10, 53–62.
104. Petito C. K. Morgello S. Felix J. C. Lesser M. L. (1990). The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab 10, 850–59.
105. Petrova P. Raibekas A. Pevsner J. Vigo N. Anafi M. Moore M. K. Peaire A. E. Shridhar V. Smith D. I. Kelly J. Durocher Y. Commissiong J. W. (2003). MANF: A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci 20, 173–88.
106. Pichili V. B. Rao K. V. Jayakumar A. R. Norenberg M. D. (2007). Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity. Glia 55, 801–9.
107. Pilbeam C. M. Anderson R. M. Bhathal P. S. (1983). The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models. J Pathol 140, 331–45.
108. Pimplikar S. W. (2009). Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41, 1261–68.
109. Przedborski S. Jackson-Lewis V. (2000). ROS and Parkinson’s disease: A view to a kill. In Free Radicals in Brain Pathophysiology (Poli G. Cadenas E. Packer L. eds.), pp. 273–90. New York, NY: Marcel Dekker.
110. Raff M. C. Lillien L. E. Richardson W. D. Burne J. F. Noble M. D. (1988). Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333, 562–65.
111. Rama Rao K. V. Chen M. Simard J. M. Norenberg M. D. (2003). Suppression of ammonia-induced astrocyte swelling by cyclosporin A. J Neurosci Res 74, 891–97.
112. Rama Rao K. V. Reddy P. V. Tong X. Norenberg M. D. (2010). Brain edema in acute liver failure: Inhibition by L-histidine. Am J Pathol 176, 1400–1408.
113. Ransom B. R. Sontheimer H. (1992). The neurophysiology of glial cells. J Clin Neurophysiol 9, 224–51.
114. Record C. O. Buxton B. Chase R. A. Curzon G. Murray-Lyon I. M. Williams R. (1976). Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 6, 387–94.
115. Rodríguez J. J. Olabarria M. Chvatal A. Verkhratsky A. (2009). Astroglia in dementia and Alzheimer’s disease. Cell Death Differ 16, 378–85.
116. Romero-Gomez M. Jover M. Diaz-Gomez D. de Teran L. C. Rodrigo R. Camacho I. Echevarria M. Felipo V. Bautista J. D. (2006). Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis. World J Gastroenterol 12, 2406–11.
117. Rossi D. Brambilla L. Valori C. F. Crugnola A. Giaccone G. Capobianco R. Mangieri M. Kingston A. E. Bloc A. Bezzi P. Volterra A. (2005). Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J Biol Chem 280, 42088–96.
118. Rothstein J. D. Dykes-Hoberg M. Pardo C. A. Bristol L. A. Jin L. Kuncl R. W. Kanai Y. Hediger M. A. Wang Y. Schielke J. P. Welty D. F. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675–86.
119. Rouach N. Avignone E. Meme W. Koulakoff A. Venance L. Blomstrand F. Giaume C. (2002). Gap junctions and connexin expression in the normal and pathological central nervous system. Biol Cell 94, 457–75.
120. Rudge J. S. (1993). Astrocyte-derived neurotrophic factors. In Astrocytes: Pharmacology and Function (Murphy S. Ed.), pp. 267–305. San Diego, CA: Academic Press.
121. Rushmore T. H. Morton M. R. Pickett C. B. (1991). The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266, 11632–39.
122. Sagara J. I. Miura K. Bannai S. (1993). Maintenance of neuronal glutathione by glial cells. J Neurochem 61, 1672–76.
123. Saito R. Graf R. Hubel K. Fujita T. Rosner G. Heiss W. D. (1997). Reduction of infarct volume by halothane: Effect on cerebral blood flow or perifocal spreading depression-like depolarizations. J Cereb Blood Flow Metab 17, 857–64.
124. Schousboe A. (1981). Transport and metabolism of glutamate and GABA in neurons and glial cells. Int Rev Neurobiol 22, 1–45.
125. Senitz D. Reichenbach A. Smith T. G. (1995). Surface complexity of human neocortical astrocytic cells: Changes with development, aging, and dementia. J Hirnforsch 36, 531–37.
126. Serres S. Bezancon E. Franconi J. M. Merle M. (2004). Ex vivo analysis of lactate and glucose metabolism in the rat brain under different states of depressed activity. J Biol Chem 279, 47881–89.
127. Serres S. Bezancon E. Franconi J. M. Merle M. (2005). Ex vivo NMR study of lactate metabolism in rat brain under various depressed states. J Neurosci Res 79, 19–25.
128. Serres S. Bouyer J. J. Bezancon E. Canioni P. Merle M. (2003). Involvement of brain lactate in neuronal metabolism. NMR Biomed 16, 430–39.
129. Shank R. P. Bennett G. S. Freytag S. O. Campbell G. L. (1985). Pyruvate carboxylase: An astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res 329, 364–67.
130. Shanker G. Allen J. W. Mutkus L. A. Aschner M. (2001). The uptake of cysteine in cultured primary astrocytes and neurons. Brain Res 902, 156–63.
131. Shawcross D. L. Balata S. Olde Damink S. W. Hayes P. C. Wardlaw J. Marshall I. Deutz N. E. Williams R. Jalan R. (2004). Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 287, G503–9.
132. Shawcross D. Jalan R. (2005). The pathophysiologic basis of hepatic encephalopathy: Central role for ammonia and inflammation. Cell Mol Life Sci 62, 2295–2304.
133. Siushansian R. Bechberger J. F. Cechetto D. F. Hachinski V. C. Naus C. C. (2001). Connexin43 null mutation increases infarct size after stroke. J Comp Neurol Nov 26, 387–94.
134. Storck T. Schulte S. Hofmann K. Stoffel W. (1992). Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 89, 10955–59.
135. Takahashi H. Koehler R. C. Brusilow S. W. Traystman R. J. (1991). Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 261, H825–29.
136. Thompson R. J. MacVicar B.A. (2008). Connexin and pannexin hemichannels of neurons and astrocytes. Channels 2, 81–86.
137. Tian G. Kong Q. Lai L. Ray-Chaudhury A. Lin C. L. (2010). Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: A potential role in Alzheimer’s disease. J Neurochem 113, 978–89.
138. Traber P. G. Dal Canto M. Ganger D. R. Blei A. T. (1987). Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: Ultrastructure and integrity of the blood-brain barrier. Hepatology 7, 1272–77.
139. van den Berg C. J. Garfinkel D. (1971). A stimulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J 123, 211–18.
140. Vincent V. A. Tilders F. J. Van Dam A. M. (1997). Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor beta. Glia 19, 190–98.
141. Walz W. (1989). Role of glial cells in the regulation of the brain ion microenvironment. Prog Neurobiol 33, 309–33.
142. Wang X. F. Cynader M. S. (2000). Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 74, 1434–42.
143. Warren K. S. Schenker S. (1964). Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 64, 442–49.
144. Wegiel J. Wang K. C. Tarnawski M. Lach B. (2000). Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol 100, 356–64.
145. Westergaard N. Drejer J. Schousboe A. Sonnewald U. (1996). Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate. Glia 17, 160–68.
146. Wright G. Soper R. Brooks H. F. Stadlbauer V. Vairappan B. Davies N. A. Andreola F. Hodges S. Moss R. F. Davies D. C. Jalan R. (2010). Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol 53, 91–97.
147. Wyss-Coray T. Loike J. D. Brionne T. C. Lu E. Anankov R. Yan F. Silverstein S. C. Husemann J. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9, 453–57.
148. Xu L. Emery J. F. Ouyang Y. B. Voloboueva L. A. Giffard R. G. (2010). Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia 58, 1042–49.
149. Yankner B. A. Duffy L. K. Kirschner D. A. (1990). Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250, 279–82.
150. Yu A. C. Drejer J. Hertz L. Schousboe A. (1983). Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem 41, 1484–87.
151. Zhang W. Qin L. Wang T. Wei S. J. Gao H. M. Liu J. Wilson B. Liu B. Kim H. C. Hong J. S. (2005). 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J 19, 395–97.
152. Zielinska M. Stafiej A. Law R. O. Albrecht J. (2004). Effects of methionine sulfoximine on the glutamine and glutamate content and cell volume in rat cerebral cortical slices: Involvement of mechanisms not related to inhibition of glutamine synthesis. Neurotoxicology 25, 443–49.
153. Zwingmann C. Chatauret N. Leibfritz D. Butterworth R. F. (2003). Selective increase of brain lactate synthesis in experimental acute liver failure: Results of a [H-C] nuclear magnetic resonance study. Hepatology 37, 420–28.
154. Zwingmann C. Chatauret N. Rose C. Leibfritz D. Butterworth R. F. (2004). Selective alterations of brain osmolytes in acute liver failure: Protective effect of mild hypothermia. Brain Res 999, 118–23.